Glutaminyl Cyclase, Diseases, and Development of Glutaminyl

Computational Methods for the Design and Development of Glutaminyl Cyclase Inhibitors in Alzheimer's Disease

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

Full article: Hypothesis: glutaminyl cyclase inhibitors decrease risks of Alzheimer's disease and related dementias

In vitro and in silico determination of glutaminyl cyclase inhibitors - RSC Advances (RSC Publishing)

Computational Methods for the Design and Development of Glutaminyl Cyclase Inhibitors in Alzheimer's Disease

Pyroglutamate Aβ cascade as drug target in Alzheimer's disease

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease

IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes

Marine Drugs, Free Full-Text